This is nicely exemplified in the case of cancer: inappropriate ZEB2 (over)expression correlates with bad prognosis of human early T-cell precursor leukemia, gastric cancer and melanoma, indicating that in healthy cells ZEB2 protein and activity need to be precisely controlled [41]. The gene discussed is ZEB2; the disease is gastric cancer.